Venous Thromboembolism Prophylaxis Policy - Royal United ...

More documents

Recommendations

Info

Appendix 2c: Cancer and Central Catheters Thromboprophylaxis Guideline Cancer patients • If the patient is having oncological treatment and is ambulant – mechanical and pharmacological thromboprophylaxis are not routinely indicated • If the patient is assessed as having additional risks for VTE use dalteparin if no contraindications Patients with central venous catheters • Do not routinely offer pharmacological or mechanical VTE prophylaxis to patients with central venous catheters who are ambulant • If the patient is high risk for VTE consider dalteparin if no contraindications Document name: Venous Thromboembolism Prophylaxis Ref.: 795 Issue date: 30 July 2014 Status: Final Author: Josephine Crowe – Consultant Haematologist Page 24 of 57
Patients with cancer Patients with central catheters Is patient having oncological treatment and ambulant? Is patient ambulant? Yes No Yes No Do not routinely offer pharmacological or mechanical VTE prophylaxis VTE risk increased? Do not routinely offer pharmacological or mechanical VTE prophylaxis VTE risk increased? Yes No Yes No Use LMWH 1 (Dalteparin) if no contraindications, or UFH 2 Continue until patient no longer at increased risk of VTE Use LMWH 1 (Dalteparin) if no contraindications, or UFH 2 Reasses within 24 hours of admission and whenever clinical situation changes 1 See Methods of Prophylaxis 2 For patients with renal failure (eGFR
Page 1 and 2: Venous Thromboembolism Prophylaxis
Page 3 and 4: Appendix 2: General Medicine Thromb
Page 5 and 6: 3 Definition of Terms Used AES DH D
Page 7 and 8: Surgical patients on the combined o
Page 9 and 10: 7.2 Pharmacological prophylaxis and
Page 11 and 12: • Untreated inherited bleeding di
Page 13 and 14: Intermittent pneumatic compression
Page 15 and 16: References 1. Scottish Intercollegi
Page 17 and 18: Appendix 1: Guideline for the Preve
Page 19 and 20: Appendix 2: Guideline General Medic
Page 21 and 22: Sequential Compression Devices for
Page 23: PATIENTS IN PALLIATIVE CARE If pati
Page 27 and 28: Antenatal VTE risk assessment Previ
Page 29 and 30: Ante-natal or postnatal weight 170
Page 31 and 32: • Varicose veins with phlebitis
Page 33 and 34: Appendix 4a: Vascular, Gastrointest
Page 35 and 36: Patients undergoing general surgery
Page 37 and 38: Patients having day surgery If VTE
Page 39 and 40: • HRT or oestrogen-containing con
Page 41 and 42: Dalteparin Rivaroxaban 10mg po OD T
Page 43 and 44: ELECTIVE HIP REPLACEMENT ELECTIVE K
Page 45 and 46: UKA, TKA, revision TKA • IPC (kne
Page 47 and 48: HIP FRACTURE OTHER ORTHOPAEDIC SURG
Page 49 and 50: Appendix 5b: Trauma and Orthopaedic
Page 51 and 52: Appendix 5c: Trauma and Orthopaedic
Page 53 and 54: Appendix 6: Critical Care Thrombopr
Page 55 and 56: Document Control Information Ratifi
Page 57: Equality Impact: (A) Assessment Scr

Venous Thromboembolism Prophylaxis Policy - Royal United ...

Create successful ePaper yourself

Delete template?

Save as template?